Chris Basta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immutep Announces Positive Preliminary Topline Results From TACTI-003 Cohort B

Immutep Announces Positive Preliminary Topline Results From TACTI-003 Cohort B
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesChris bastaImmutep limitedMerck sharp dohmeMerck co incInternational agency for research on cancerDrug administrationCorporate communicationsMedia releaseCombined positive scoreMerck sharpOverall response rateOverall survivalProgression free survivalEftilagimod alpha

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New south walesMatthijs moerlandChris bastaPediatric researchImmutep limitedCentre for human drug researchCorporate communicationsAppoints leading research instituteConduct first in human phasei studyHuman drug researchChief scientific officerDirector immunologyPrincipal investigatorLymphocyte activationInvestor relationsCurr opin

Immutep Quarterly Activities Report Q2 FY24

Media Release Excellent clinical data reported from TACTI-002 Phase II trial, including median Overall Survival of 35.5 months in first line non-small cell lung cancer patients expressing PD-L1.

New south walesSouth australiaChris bastaFrederic triebelJamie rossjohnCorporate communicationsKorean intellectual property officeMerck kgaCommittee for medicinal products human useData monitoring committeeMonash universityImmutep limitedGlobenewswire incMerck kgaaOverall survivalOverall response rate

First Patient Dosed in Trial Evaluating Efti and the Anti-PD-L1 Therapy BAVENCIO® in Metastatic Urothelial Cancer

Media ReleaseSYDNEY, AUSTRALIA, Jan. 04, 2024 (GLOBE NEWSWIRE) Immutep Limited (ASX: IMM; NASDAQ: IMMP) ( Immutep” or “the Company”), a clini.

United statesNew south walesKrankenhaus nordwestChris bastaDrug administrationImmutep limitedUs national cancer instituteMerck kgaaInstitute of clinical cancer researchCorporate communicationsMerck kgaClinical cancer researchHelios klinikum bad saarowDaniel pinkEftilagimod alphaFast track

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Nordrhein westfalenNew south walesUnited statesSalah eddin al batranChris bastaMerck co incMerck sharp dohmeUniversity clinic of ruhr universitCorporate communicationsFrankfurt institute of clinical cancer researchImmutep limitedAnnounces site expansionUniversity clinicRuhr universitLung clinicProportion score